Evidence map›Paper›PMID 32354916›Full record

ArticleIn vivo (Athens, Greece)

Predictive Ability of Preoperative PT-INR and Postoperative MCP1 for Post-hepatectomy Liver Failure.

Sayaka Arisaka, Ryusei Matsuyama, Koki Goto, Yusuke Suwa, Ryutaro Mori, Daisuke Morioka, Masataka Taguri, Itaru Endo

Open access · diamondAbstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sayaka ArisakaDepartment of Gastroenterological Surgery, Yokohama City University, Yokohama, Japan.
Ryusei MatsuyamaDepartment of Gastroenterological Surgery, Yokohama City University, Yokohama, Japan.
Koki GotoDepartment of Gastroenterological Surgery, Yokohama City University, Yokohama, Japan.
Yusuke SuwaDepartment of Gastroenterological Surgery, Yokohama City University, Yokohama, Japan.
Ryutaro MoriDepartment of Gastroenterological Surgery, Yokohama City University, Yokohama, Japan.
Daisuke MoriokaDepartment of Gastroenterological Surgery, Yokohama City University, Yokohama, Japan.
Masataka TaguriDepartment of Biostatistics, Yokohama City University, Yokohama, Japan.
Itaru EndoDepartment of Gastroenterological Surgery, Yokohama City University, Yokohama, Japan endoit@yokohama-cu.ac.jp.
Yokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe sought a diagnostic tool using perioperative variables that might predict post-hepatectomy liver failure (PHLF). PATIENTS AND

methodsIn 68 patients undergoing major hepatectomy, data on inflammatory markers and coagulation factors were prospectively collected and were compared between patients with International Study Group of Liver Surgery definition grade B/C PHLF (LF group) and those without LF (non-LF group).

resultsPreoperatively, the LF group (n=9; 13.2%) had a lower platelet count and a disintegrin-like and metalloproteinase with thrombospondin type 1 motifs 13 (ADAMTS13) activity and a higher prothrombin time-International Normalized Ratio (PT-INR) than the non-LF group. On postoperative day 1, the LF group had significantly higher serum interleukin 6 (IL6), C-C motif chemokine ligand 2 (CCL2), and IL10 levels than the non-LF group. The logistic regression model that included preoperative PT-INR and CCL2 on postoperative day 1 predicted grade B/C PHLF with 100% sensitivity and 89.8% specificity.

conclusionOur findings suggest that the combination of preoperative PT-INR and CCL2 on postoperative day 1 can predict PHLF earlier and precisely after major hepatectomy.

Indexed as

International Normalized RatioBiomarkersChemokine CCL2CytokinesFemaleHepatectomyHumansInflammation MediatorsLiver FailureMalePostoperative ComplicationsPostoperative PeriodPreoperative PeriodROC CurveBiomarkersCCL2 protein, humanChemokine CCL2CytokinesInflammation Mediatorscoagulation factorinflammatory markerMajor hepatectomypost-hepatectomy liver failurepredictive model

Identifiers

PMID32354916
PMCPMC7279821
OpenAlexW3023617389

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.